Biocartis Idylla MSI Assay

Biocartis announced today that it has launched its automated Idylla MSI assay. The research-use-only assay provides information on the microsatellite instability-status of a tumor in about 150 minutes from one slice of FFPE tumor tissue without requiring a reference sample. The assay includes a set of seven MSI biomarkers, including ACVR2A, BTBD7, DID01, MRE11, RYR3, SEC31A, and SULF2 genes.